Equities

Jianmin Pharmaceutical Group Co Ltd

600976:SHH

Jianmin Pharmaceutical Group Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (CNY)40.60
  • Today's Change-1.59 / -3.77%
  • Shares traded1.63m
  • 1 Year change-34.51%
  • Beta1.8337
Data delayed at least 15 minutes, as of Sep 13 2024 08:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of CNY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments963861840
Total Receivables, Net1,224910718
Total Inventory451363223
Prepaid expenses9012382
Other current assets, total38480.59
Total current assets2,7662,3051,863
Property, plant & equipment, net463418417
Goodwill, net0.210.210.21
Intangibles, net344243
Long term investments659454337
Note receivable - long term------
Other long term assets--23--
Total assets4,1683,4402,856
LIABILITIES
Accounts payable403312208
Accrued expenses583055
Notes payable/short-term debt459321212
Current portion long-term debt/capital leases5.127.346.10
Other current liabilities, total932862838
Total current liabilities1,8571,5341,319
Total long term debt302320
Total debt494352239
Deferred income tax5.625.970.84
Minority interest8.784.997.04
Other liabilities, total191228
Total liabilities1,9201,5801,375
SHAREHOLDERS EQUITY
Common stock153153153
Additional paid-in capital521509422
Retained earnings (accumulated deficit)1,5801,212931
Treasury stock - common(6.76)(15)(25)
Unrealized gain (loss)------
Other equity, total------
Total equity2,2481,8601,481
Total liabilities & shareholders' equity4,1683,4402,856
Total common shares outstanding153153153
Treasury shares - common primary issue0.450.450.45
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.